For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
MedicalXpress Breaking News-and-Events | Jun 06, 2023
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
MedicalXpress Breaking News-and-Events | Jun 06, 2023
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
MedicalXpress Breaking News-and-Events | May 17, 2023
New insights into liver cancer using organoids
MedicalXpress Breaking News-and-Events | May 04, 2023
Clinical screening can identify fear of cancer recurrence
MedicalXpress Breaking News-and-Events | May 03, 2023
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumours
MedicalXpress Breaking News-and-Events | Apr 29, 2023
Spatial patterns of immune cells predict patient outcomes in clear cell renal cell carcinoma
MedicalXpress Breaking News-and-Events | Apr 28, 2023
Non-canonical proteins as candidate targets for cancer immunotherapy
MedicalXpress Breaking News-and-Events | Mar 23, 2023
I was diagnosed with colon cancer in my 30s: Here's how I'm coping today
MDlinx | Mar 08, 2023
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors
MedicalXpress Breaking News-and-Events | Feb 24, 2023